Transcriptional regulation of de novo lipogenesis in liver

Hepatic De Novo Lipogenesis and Regulation of Metabolism

Volumn , Issue , 2015, Pages 1-31

  Zhang, Deqiang ^a   Yin, Lei ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

ChREBP; De novo lipogenesis; Insulin; Metabolic syndromes; SREBP 1c

Indexed keywords

EID: 85008970966     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-25065-6_1     Document Type: Chapter

References (211)

1. Abdelmalek MF, Diehl AM (2007) Nonalcoholic fatty liver disease as a complication of insulin resistance. Med Clin North Am 91(6): 1125-1149
2. Abu-Elheiga L, Almarza-Ortega DB, Baldini A, Wakil SJ (1997) Human acetyl-CoA carboxylase 2 molecular cloning, characterization, chromosomal mapping, and evidence for two isoforms. J Biol Chem 272(16): 10669-10677
3. Abu-Elheiga L, Matzuk MM, Kordari P, Oh W, Shaikenov T, Gu Z, Wakil SJ (2005) Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal. Proc Natl Acad Sci U S A 102(34): 12011-12016
4. Ameer F, Scandiuzzi L, Hasnain S, Kalbacher H, Zaidi N (2014) De novo lipogenesis in health and disease. Metabolism 63(7): 895-902
5. Amemiya-Kudo M, Shimano H, Yoshikawa T, Yahagi N, Hasty AH, Okazaki H, Tamura Y, Shionoiri F, Iizuka Y, Ohashi K (2000) Promoter analysis of the mouse sterol regulatory element- binding protein-1c gene. J Biol Chem 275(40): 31078-31085
6. Ariyama H, Kono N, Matsuda S, Inoue T, Arai H (2010) Decrease in membrane phospholipid unsaturation induces unfolded protein response. J Biol Chem 285(29): 22027-22035
7. Asher G, Schibler U (2011) Crosstalk between components of circadian and metabolic cycles in mammals. Cell Metab 13(2): 125-137
8. Barak Y, Kim S (2007) Genetic manipulations of PPARs: effects on obesity and metabolic disease. PPAR Res 2007: 12781
9. Bartlett K, Eaton S (2004) Mitochondrial β-oxidation. Eur J Biochem 271(3): 462-469
10. Beckers A, Organe S, Timmermans L, Scheys K, Peeters A, Brusselmans K, Verhoeven G, Swinnen JV (2007) Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells. Cancer Res 67(17): 8180-8187
11. Bengoechea-Alonso MT, Ericsson J (2009) A phosphorylation cascade controls the degradation of active SREBP1. J Biol Chem 284(9): 5885-5895
12. Benhamed F, Denechaud P-D, Lemoine M, Robichon C, Moldes M, Bertrand-Michel J, Ratziu V, Serfaty L, Housset C, Capeau J (2012) The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J Clin Invest 122(6): 2176-2194
13. Bergot M-O, Diaz-Guerra M-JM, Puzenat N, Raymondjean M, Kahn A (1992) Cis-regulation of the L-type pyruvate kinase gene promoter by glucose, insulin and cyclic AMP. Nucleic Acids Res 20(8): 1871-1878
14. Björntorp P, Sjöström L (1978) Carbohydrate storage in man: speculations and some quantitative considerations. Metabolism 27(12): 1853-1865
15. Bobrovnikova-Marjon E, Hatzivassiliou G, Grigoriadou C, Romero M, Cavener DR, Thompson CB, Diehl JA (2008) PERK-dependent regulation of lipogenesis during mouse mammary gland development and adipocyte differentiation. Proc Natl Acad Sci U S A 105(42): 16314-16319
16. Bravo R, Parra V, Gatica D, Rodriguez AE, Torrealba N, Paredes F, Wang ZV, Zorzano A, Hill JA, Jaimovich E (2013) Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration. Int Rev Cell Mol Biol 301: 215
17. Bricambert J, Miranda J, Benhamed F, Girard J, Postic C, Dentin R (2010) Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. J Clin Invest 120(12): 4316-4331
18. Brown MS, Goldstein JL (1997) The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89(3): 331-340
19. Brown MS, Goldstein JL (2008) Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 7(2): 95-96
20. Buettner R, Ottinger I, Schölmerich J, Bollheimer LC (2004) Preserved direct hepatic insulin action in rats with diet-induced hepatic steatosis. Am J Physiol Endocrinol Metab 286(5): E828-E833
21. Bugge A, Feng D, Everett LJ, Briggs ER, Mullican SE, Wang F, Jager J, Lazar MA (2012) Reverbα and Rev-erbβ coordinately protect the circadian clock and normal metabolic function. Genes Dev 26(7): 657-667
22. Bunger MK, Wilsbacher LD, Moran SM, Clendenin C, Radcliffe LA, Hogenesch JB, Simon MC, Takahashi JS, Bradfield CA (2000) Mop3 is an essential component of the master circadian pacemaker in mammals. Cell 103(7): 1009-1017
23. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE (2005) Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat Med 11(2): 183-190
24. Calkin AC, Tontonoz P (2010) Liver x receptor signaling pathways and atherosclerosis. Arterioscler Thromb Vasc Biol 30(8): 1513-1518
25. Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S, Destefanis G, Delogu S, Zimmermann A, Ericsson J (2011) Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology 140(3): 1071-1083.e1075
26. Chakravarthy MV, Pan Z, Zhu Y, Tordjman K, Schneider JG, Coleman T, Turk J, Semenkovich CF (2005) "New" hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab 1(5): 309-322
27. Chen G, Liang G, Ou J, Goldstein JL, Brown MS (2004) Central role for liver X receptor in insulin- mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci U S A 101(31): 11245-11250
28. Cho H, Zhao X, Hatori M, Ruth TY, Barish GD, Lam MT, Chong L-W, DiTacchio L, Atkins AR, Glass CK (2012) Regulation of circadian behaviour and metabolism by REV-ERB-[agr] and REV-ERB-[bgr]. Nature 485(7396): 123-127
29. Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA, Sharma R, Hudgins LC, Ntambi JM, Friedman JM (2002) Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297(5579): 240-243
30. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378(6559): 785-789
31. Cuif M, Porteu A, Kahn A, Vaulont S (1993) Exploration of a liver-specific, glucose/insulinresponsive promoter in transgenic mice. J Biol Chem 268(19): 13769-13772
32. Currie E, Schulze A, Zechner R, Walther TC, Farese RV (2013) Cellular fatty acid metabolism and cancer. Cell Metab 18(2): 153-161
33. Davies MN, O’Callaghan BL, Towle HC (2010) Activation and repression of glucose-stimulated ChREBP requires the concerted action of multiple domains within the MondoA conserved region. Am J Physiol Endocrinol Metab 299(4): E665-E674
34. Dentin R, Pégorier J-P, Benhamed F, Foufelle F, Ferré P, Fauveau V, Magnuson MA, Girard J, Postic C (2004) Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J Biol Chem 279(19): 20314-20326
35. Dentin R, Benhamed F, Pégorier J-P, Foufelle F, Viollet B, Vaulont S, Girard J, Postic C (2005) Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation. J Clin Invest 115(10): 2843-2854
36. Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, Girard J, Postic C (2006) Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 55(8): 2159-2170
37. Dentin R, Langin D, Postic C (2012) Hidden variant of ChREBP in fat links lipogenesis to insulin sensitivity. Cell Metab 15(6): 795-797
38. Dibble CC, Asara JM, Manning BD (2009) Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Mol Cell Biol 29(21): 5657-5670
39. Doiron B, Cuif M-H, Kahn A, Diaz-Guerra M (1994) Respective roles of glucose, fructose, and insulin in the regulation of the liver-specific pyruvate kinase gene promoter. J Biol Chem 269(14): 10213-10216
40. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115(5): 1343
41. Düvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 39(2): 171-183
42. Eissing L, Scherer T, Tödter K, Knippschild U, Greve JW, Buurman WA, Pinnschmidt HO, Rensen SS, Wolf AM, Bartelt A (2013) De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health. Nat Commun 4: 1528
43. Enomoto N, Ikejima K, Yamashina S, Enomoto A, Nishiura T, Nishimura T, Brenner DA, Schemmer P, Bradford BU, Rivera CA (2000) Kupffer cell-derived prostaglandin E2 is involved in alcohol-induced fat accumulation in rat liver. Am J Physiol Gastrointest Liver Physiol 279(1): G100-G106
44. Erion DM, Popov V, Hsiao JJ, Vatner D, Mitchell K, Yonemitsu S, Nagai Y, Kahn M, Gillum MP, Dong J (2012) The role of the carbohydrate response element-binding protein in male fructosefed rats. Endocrinology 154(1): 36-44
45. Ettinger SL, Sobel R, Whitmore TG, Akbari M, Bradley DR, Gleave ME, Nelson CC (2004) Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence. Cancer Res 64(6): 2212-2221
46. Feng D, Liu T, Sun Z, Bugge A, Mullican SE, Alenghat T, Liu XS, Lazar MA (2011) A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. Science 331(6022): 1315-1319
47. Ferre P, Foufelle F (2010) Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes Obes Metab 12(s2): 83-92
48. Ferre T, Riu E, Bosch F, Valera A (1996) Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver. FASEB J 10(10): 1213-1218
49. Filhoulaud G, Guilmeau S, Dentin R, Girard J, Postic C (2013) Novel insights into ChREBP regulation and function. Trends Endocrinol Metab 24(5): 257-268
50. Fisher EA (2012) The degradation of apolipoprotein B100: multiple opportunities to regulate VLDL triglyceride production by different proteolytic pathways. Biochim Biophys Acta 1821(5): 778-781
51. Fritz V, Benfodda Z, Rodier G, Henriquet C, Iborra F, Avancès C, Allory Y, De La Taille A, Culine S, Blancou H (2010) Abrogation of de novo lipogenesis by stearoyl-CoA desaturase 1 inhibition interferes with oncogenic signaling and blocks prostate cancer progression in mice. Mol Cancer Ther 9(6): 1740-1754
52. Fukasawa M, Ge Q, Wynn RM, Ishii S, Uyeda K (2010) Coordinate regulation/localization of the carbohydrate responsive binding protein (ChREBP) by two nuclear export signal sites: discovery of a new leucine-rich nuclear export signal site. Biochem Biophys Res Commun 391(2): 1166-1169
53. Giandomenico V, Simonsson M, Grönroos E, Ericsson J (2003) Coactivator-dependent acetylation stabilizes members of the SREBP family of transcription factors. Mol Cell Biol 23(7): 2587-2599
54. Gibbons GF, Islam K, Pease RJ (2000) Mobilisation of triacylglycerol stores. Biochim Biophys Acta 1483(1): 37-57
55. Girard J, Ferré P, Foufelle F (1997) Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes. Annu Rev Nutr 17(1): 325-352
56. Goldstein JL, DeBose-Boyd RA, Brown MS (2006) Protein sensors for membrane sterols. Cell 124(1): 35-46
57. Graner E, Tang D, Rossi S, Baron A, Migita T, Weinstein LJ, Lechpammer M, Huesken D, Zimmermann J, Signoretti S (2004) The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. Cancer Cell 5(3): 253-261
58. Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29: 415-445
59. Griffiths B, Lewis CA, Bensaad K, Ros S, Zhang Q, Ferber EC, Konisti S, Peck B, Miess H, East P (2013) Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth. Cancer Metab 1(3)
60. Gross DN, Wan M, Birnbaum MJ (2009) The role of FOXO in the regulation of metabolism. Curr Diab Rep 9(3): 208-214
61. Grunfeld C, Adi S, Soued M, Moser A, Fiers W, Feingold KR (1990) Search for mediators of the lipogenic effects of tumor necrosis factor: potential role for interleukin 6. Cancer Res 50(14): 4233-4238
62. Guinez C, Filhoulaud G, Rayah-Benhamed F, Marmier S, Dubuquoy C, Dentin R, Moldes M, Burnol A-F, Yang X, Lefebvre T (2011) O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes 60(5): 1399-1413
63. Guo D, Prins RM, Dang J, Kuga D, Iwanami A, Soto H, Lin KY, Huang TT, Akhavan D, Hock MB (2009) EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to anti-lipogenic therapy. Sci Signal 2(101): ra82
64. Ha J, Lee J-K, Kim K-S, Witters LA, Kim K-H (1996) Cloning of human acetyl-CoA carboxylasebeta and its unique features. Proc Natl Acad Sci U S A 93(21): 11466-11470
65. Harada N, Oda Z, Hara Y, Fujinami K, Okawa M, Ohbuchi K, Yonemoto M, Ikeda Y, Ohwaki K, Aragane K (2007) Hepatic de novo lipogenesis is present in liver-specific ACC1-deficient mice. Mol Cell Biol 27(5): 1881-1888
66. Hardie DG, Ross FA, Hawley SA (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 13(4): 251-262
67. Hariharan N, Farrelly D, Hagan D, Hillyer D, Arbeeny C, Sabrah T, Treloar A, Brown K, Kalinowski S, Mookhtiar K (1997) Expression of human hepatic glucokinase in transgenic mice liver results in decreased glucose levels and reduced body weight. Diabetes 46(1): 11-16
68. Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, Hingorani SR, Tuveson DA, Thompson CB (2005) ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8(4): 311-321
69. Havula E, Hietakangas V (2012) Glucose sensing by ChREBP/MondoA-Mlx transcription factors. Semin Cell Dev Biol 23(6): 640-647
70. Hegarty BD, Bobard A, Hainault I, Ferré P, Bossard P, Foufelle F (2005) Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element binding protein-1c. Proc Natl Acad Sci U S A 102(3): 791-796
71. Hemmings BA, Restuccia DF (2012) Pi3k-pkb/akt pathway. Cold Spring Harb Perspect Biol 4(9): a011189
72. Hems DA, Rath EA, Verrinder TR (1975) Fatty acid synthesis in liver and adipose tissue of normal and genetically obese (ob/ob) mice during the 24-hour cycle. Biochem J 150: 167-173
73. Herman MA, Peroni OD, Villoria J, Schön MR, Abumrad NA, Blüher M, Klein S, Kahn BB (2012) A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature 484(7394): 333-338
74. Hirano Y, Yoshida M, Shimizu M, Sato R (2001) Direct demonstration of rapid degradation of nuclear sterol regulatory element-binding proteins by the ubiquitin-proteasome pathway. J Biol Chem 276(39): 36431-36437
75. Hodson L, Fielding BA (2013) Stearoyl-CoA desaturase: rogue or innocent bystander? Prog Lipid Res 52(1): 15-42
76. Horton JD, Bashmakov Y, Shimomura I, Shimano H (1998) Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice. Proc Natl Acad Sci U S A 95(11): 5987-5992
77. Horton JD, Goldstein JL, Brown MS (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109(9): 1125-1131
78. Houtkooper RH, Pirinen E, Auwerx J (2012) Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 13(4): 225-238
79. Huang J, Manning BD (2009) A complex interplay between Akt, TSC2, and the two mTOR complexes. Biochem Soc Trans 37(Pt 1): 217
80. Hudgins LC, Seidman CE, Diakun J, Hirsch J (1998) Human fatty acid synthesis is reduced after the substitution of dietary starch for sugar. Am J Clin Nutr 67(4): 631-639
81. Ido-Kitamura Y, Sasaki T, Kobayashi M, Kim H-J, Lee Y-S, Kikuchi O, Yokota-Hashimoto H, Iizuka K, Accili D, Kitamura T (2012) Hepatic FoxO1 integrates glucose utilization and lipid synthesis through regulation of Chrebp O-glycosylation. PLoS One 7(10): e47231
82. Iizuka K, Bruick RK, Liang G, Horton JD, Uyeda K (2004) Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis. Proc Natl Acad Sci U S A 101(19): 7281-7286
83. Iizuka K, Miller B, Uyeda K (2006) Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice. Am J Physiol Endocrinol Metab 291(2): E358-E364
84. Jakobsson A, Westerberg R, Jacobsson A (2006) Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res 45(3): 237-249
85. Kabashima T, Kawaguchi T, Wadzinski BE, Uyeda K (2003) Xylulose 5-phosphate mediates glucose- induced lipogenesis by xylulose 5-phosphate-activated protein phosphatase in rat liver. Proc Natl Acad Sci U S A 100(9): 5107-5112
86. Kammoun HL, Chabanon H, Hainault I, Luquet S, Magnan C, Koike T, Ferré P, Foufelle F (2009) GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest 119(5): 1201-1215
87. Kawaguchi T, Takenoshita M, Kabashima T, Uyeda K (2001) Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation/dephosphorylation of the carbohydrate response element binding protein. Proc Natl Acad Sci U S A 98(24): 13710-13715
88. Kawaguchi T, Osatomi K, Yamashita H, Kabashima T, Uyeda K (2002) Mechanism for fatty acid "sparing" effect on glucose-induced transcription regulation of carbohydrate-responsive element- binding protein by AMP-activated protein kinase. J Biol Chem 277(6): 3829-3835
89. Kersten S (2001) Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep 2(4): 282-286
90. Kersten S, Desvergne B, Wahli W (2000) Roles of PPARs in health and disease. Nature 405(6785): 421-424
91. Kim KH, Song MJ, Yoo EJ, Choe SS, Dai Park S, Kim JB (2004) Regulatory role of glycogen synthase kinase 3 for transcriptional activity of ADD1/SREBP1c. J Biol Chem 279(50): 51999-52006
92. Kim H-S, Xiao C, Wang R-H, Lahusen T, Xu X, Vassilopoulos A, Vazquez-Ortiz G, Jeong W-I, Park O, Ki SH (2010) Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab 12(3): 224-236
93. Knutson SK, Chyla BJ, Amann JM, Bhaskara S, Huppert SS, Hiebert SW (2008) Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J 27(7): 1017-1028
94. Koo H-Y, Wallig MA, Chung BH, Nara TY, Cho B, Nakamura MT (2008) Dietary fructose induces a wide range of genes with distinct shift in carbohydrate and lipid metabolism in fed and fasted rat liver. Biochim Biophys Acta 1782(5): 341-348
95. Krycer JR, Sharpe LJ, Luu W, Brown AJ (2010) The Akt-SREBP nexus: cell signaling meets lipid metabolism. Trends Endocrinol Metab 21(5): 268-276
96. Le Martelot G, Claudel T, Gatfield D, Schaad O, Kornmann B, Sasso GL, Moschetta A, Schibler U (2009) REV-ERBα participates in circadian SREBP signaling and bile acid homeostasis. PLoS Biol 7(9): e1000181
97. Leavens KF, Easton RM, Shulman GI, Previs SF, Birnbaum MJ (2009) Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab 10(5): 405-418
98. Lee A-H, Scapa EF, Cohen DE, Glimcher LH (2008) Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 320(5882): 1492-1496
99. Lewis GF, Carpentier A, Adeli K, Giacca A (2002) Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23(2): 201-229
100. Li MV, Chang B, Imamura M, Poungvarin N, Chan L (2006) Glucose-dependent transcriptional regulation by an evolutionarily conserved glucose-sensing module. Diabetes 55(5): 1179-1189
101. Li X, Zhang S, Blander G, Jeanette GT, Krieger M, Guarente L (2007) SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell 28(1): 91-106
102. Li S, Brown MS, Goldstein JL (2010) Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc Natl Acad Sci U S A 107(8): 3441-3446
103. Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Park O, Luo Z, Lefai E, Shyy JY-J (2011) AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 13(4): 376-388
104. Liang G, Yang J, Horton JD, Hammer RE, Goldstein JL, Brown MS (2002) Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c. J Biol Chem 277(11): 9520-9528
105. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV, Ory DS, Schaffer JE (2003) Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A 100(6): 3077-3082
106. Lodhi IJ, Wei X, Semenkovich CF (2011) Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter. Trends Endocrinol Metab 22(1): 1-8
107. Lupu R, Menendez JA (2006) Pharmacological inhibitors of fatty acid synthase (FASN)-catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents? Curr Pharm Biotechnol 7(6): 483-494
108. Ma L, Tsatsos NG, Towle HC (2005) Direct role of ChREBP• Mlx in regulating hepatic glucoseresponsive genes. J Biol Chem 280(12): 12019-12027
109. Ma L, Robinson LN, Towle HC (2006) ChREBP* Mlx is the principal mediator of glucose-induced gene expression in the liver. J Biol Chem 281(39): 28721-28730
110. Ma L, Sham YY, Walters KJ, Towle HC (2007) A critical role for the loop region of the basic helix-loop-helix/leucine zipper protein Mlx in DNA binding and glucose-regulated transcription. Nucleic Acids Res 35(1): 35-44
111. Mannaerts GP, Van Veldhoven PP, Casteels M (2000) Peroxisomal lipid degradation via β-and α-oxidation in mammals. Cell Biochem Biophys 32(1-3): 73-87
112. Manning BD, Cantley LC (2007) AKT/PKB signaling: navigating downstream. Cell 129(7): 1261-1274
113. Mao J, DeMayo FJ, Li H, Abu-Elheiga L, Gu Z, Shaikenov TE, Kordari P, Chirala SS, Heird WC, Wakil SJ (2006) Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. Proc Natl Acad Sci U S A 103(22): 8552-8557
114. Mao J-H, Kim I-J, Wu D, Climent J, Kang HC, DelRosario R, Balmain A (2008) FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression. Science 321(5895): 1499-1502
115. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N (1999) Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 107(5): 450-455
116. Matsusue K, Haluzik M, Lambert G, Yim S-H, Gavrilova O, Ward JM, Brewer B Jr, Reitman ML, Gonzalez FJ (2003) Liver-specific disruption of PPARγ in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. J Clin Invest 111(5): 737
117. Matsuzaka T, Shimano H, Yahagi N, Kato T, Atsumi A, Yamamoto T, Inoue N, Ishikawa M, Okada S, Ishigaki N (2007) Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance. Nat Med 13(10): 1193-1202
118. Matsuzaka T, Atsumi A, Matsumori R, Nie T, Shinozaki H, Suzuki-Kemuriyama N, Kuba M, Nakagawa Y, Ishii K, Shimada M (2012) Elovl6 promotes nonalcoholic steatohepatitis. Hepatology 56(6): 2199-2208
119. Medes G, Thomas A, Weinhouse S (1953) Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res 13(1): 27-29
120. Merla G, Howald C, Antonarakis SE, Reymond A (2004) The subcellular localization of the ChoRE-binding protein, encoded by the Williams-Beuren syndrome critical region gene 14, is regulated by 14-3-3. Hum Mol Genet 13(14): 1505-1514
121. Meroni G, Cairo S, Merla G, Messali S, Brent R, Ballabio A, Reymond A (2000) Mlx, a new Maxlike bHLHZip family member: the center stage of a novel transcription factors regulatory pathway? Oncogene 19(29): 3266-3277
122. Migita T, Narita T, Nomura K, Miyagi E, Inazuka F, Matsuura M, Ushijima M, Mashima T, Seimiya H, Satoh Y (2008) ATP citrate lyase: activation and therapeutic implications in nonsmall cell lung cancer. Cancer Res 68(20): 8547-8554
123. Miyazaki M, Flowers MT, Sampath H, Chu K, Otzelberger C, Liu X, Ntambi JM (2007) Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis. Cell Metab 6(6): 484-496
124. Monetti M, Levin MC, Watt MJ, Sajan MP, Marmor S, Hubbard BK, Stevens RD, Bain JR, Newgard CB, Farese RV (2007) Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab 6(1): 69-78
125. Moon Y-A, Shah NA, Mohapatra S, Warrington JA, Horton JD (2001) Identification of a mammalian long chain fatty acyl elongase regulated by sterol regulatory element-binding proteins. J Biol Chem 276(48): 45358-45366
126. Morán-Salvador E, López-Parra M, García-Alonso V, Titos E, Martínez-Clemente M, González-Périz A, López-Vicario C, Barak Y, Arroyo V, Clària J (2011) Role for PPARγ in obesityinduced hepatic steatosis as determined by hepatocyte-and macrophage-specific conditional knockouts. FASEB J 25(8): 2538-2550
127. Munday MR, Campbell DG, Carling D, Hardie DG (1988) Identification by amino acid sequencing of three major regulatory phosphorylation sites on rat acetyl-CoA carboxylase. Eur J Biochem 175(2): 331-338
128. Nakayama KI, Nakayama K (2006) Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 6(5): 369-381
129. Neyrinck AM, Margagliotti S, Gomez C, Delzenne NM (2004) Kupffer cell-derived prostaglandin E2 is involved in regulation of lipid synthesis in rat liver tissue. Cell Biochem Funct 22(5): 327-332
130. Nimpf J, Schneider WJ (2000) From cholesterol transport to signal transduction: low density lipoprotein receptor, very low density lipoprotein receptor, and apolipoprotein E receptor-2. Biochim Biophys Acta 1529(1): 287-298
131. Niswender KD, Shiota M, Postic C, Cherrington AD, Magnuson MA (1997) Effects of increased glucokinase gene copy number on glucose homeostasis and hepatic glucose metabolism. J Biol Chem 272(36): 22570-22575
132. Nomura K, Yamanouchi T (2012) The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J Nutr Biochem 23(3): 203-208
133. Nonogaki K, Fuller GM, Fuentes NL, Moser AH, Staprans I, Grunfeld C, Feingold KR (1995) Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 136(5): 2143-2149
134. Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS, Song Y, Cohen P, Friedman JM, Attie AD (2002) Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci U S A 99(17): 11482-11486
135. Olefsky JM (2000) Treatment of insulin resistance with peroxisome proliferator-activated receptor γ agonists. J Clin Invest 106(4): 467
136. Onoyama I, Suzuki A, Matsumoto A, Tomita K, Katagiri H, Oike Y, Nakayama K, Nakayama KI (2011) Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver. J Clin Invest 121(1): 342
137. Owen JL, Zhang Y, Bae S-H, Farooqi MS, Liang G, Hammer RE, Goldstein JL, Brown MS (2012) Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase. Proc Natl Acad Sci U S A 109(40): 16184-16189
138. Parks EJ, Krauss RM, Christiansen MP, Neese RA, Hellerstein MK (1999) Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J Clin Invest 104(8): 1087-1096
139. Paton C, Stamatikos A, Rogowski M (2014) Tissue specific induction of ChREBP isoforms in carbohydrate refed mice and their impact on lipogenesis (642.8). FASEB J 28(1 Suppl): 642-648
140. Pearce J (1983) Fatty acid synthesis in liver and adipose tissue. Proc Nutr Soc 42(02): 263-271
141. Petersen KF, Shulman GI (2006) Etiology of insulin resistance. Am J Med 119(5): S10-S16
142. Peterson TR, Sengupta SS, Harris TE, Carmack AE, Kang SA, Balderas E, Guertin DA, Madden KL, Carpenter AE, Finck BN (2011) mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 146(3): 408-420
143. Ponugoti B, Kim D-H, Xiao Z, Smith Z, Miao J, Zang M, Wu S-Y, Chiang C-M, Veenstra TD, Kemper JK (2010) SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J Biol Chem 285(44): 33959-33970
144. Porstmann T, Santos CR, Griffiths B, Cully M, Wu M, Leevers S, Griffiths JR, Chung Y-L, Schulze A (2008) SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab 8(3): 224-236
145. Postic C, Girard J (2008) Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 118(3): 829
146. Postic C, Dentin R, Denechaud P-D, Girard J (2007) ChREBP, a transcriptional regulator of glucose and lipid metabolism. Annu Rev Nutr 27: 179-192
147. Punga T, Bengoechea-Alonso MT, Ericsson J (2006) Phosphorylation and ubiquitination of the transcription factor sterol regulatory element-binding protein-1 in response to DNA binding. J Biol Chem 281(35): 25278-25286
148. Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, Li X (2009) Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab 9(4): 327-338
149. Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS (2008) Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab 8(6): 512-521
150. Reddy JK, Mannaerts GP (1994) Peroxisomal lipid metabolism. Annu Rev Nutr 14(1): 343-370
151. Reddy JK, Rao MS (2006) Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 290(5): G852-G858
152. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro J-MA, Shimomura I, Shan B, Brown MS, Goldstein JL, Mangelsdorf DJ (2000) Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes Dev 14(22): 2819-2830
153. Ruan H-B, Nie Y, Yang X (2013) Regulation of protein degradation by O-GlcNAcylation: crosstalk with ubiquitination. Mol Cell Proteomics 12(12): 3489-3497
154. Rudic RD, McNamara P, Curtis A-M, Boston RC, Panda S, Hogenesch JB, FitzGerald GA (2004) BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol 2(11): e377
155. Rufo C, Teran-Garcia M, Nakamura MT, Koo S-H, Towle HC, Clarke SD (2001) Involvement of a unique carbohydrate-responsive factor in the glucose regulation of rat liver fatty-acid synthase gene transcription. J Biol Chem 276(24): 21969-21975
156. Sakiyama H, Fujiwara N, Noguchi T, Eguchi H, Yoshihara D, Uyeda K, Suzuki K (2010) The role of O -linked GlcNAc modification on the glucose response of ChREBP. Biochem Biophys Res Commun 402(4): 784-789
157. Saltiel AR, Kahn CR (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414(6865): 799-806
158. Samuel VT, Shulman GI (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148(5): 852-871
159. Savage DB, Choi CS, Samuel VT, Liu Z-X, Zhang D, Wang A, Zhang X-M, Cline GW, Yu XX, Geisler JG (2006) Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J Clin Invest 116(3): 817
160. Schonfeld G, Yue P, Lin X, Chen Z (2008) Fatty liver and insulin resistance: not always linked. Trans Am Clin Climatol Assoc 119: 217
161. Schwarz J-M, Linfoot P, Dare D, Aghajanian K (2003) Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 77(1): 43-50
162. Scott E, Carter A, Grant P (2008) Association between polymorphisms in the Clock gene, obesity and the metabolic syndrome in man. Int J Obes (Lond) 32(4): 658-662
163. Shelness GS, Sellers JA (2001) Very-low-density lipoprotein assembly and secretion. Curr Opin Lipidol 12(2): 151-157
164. Shih H-M, Liu Z, Towle HC (1995) Two CACGTG motifs with proper spacing dictate the carbohydrate regulation of hepatic gene transcription. J Biol Chem 270(37): 21991-21997
165. Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL (1997) Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest 99(5): 846
166. Shimba S, Ogawa T, Hitosugi S, Ichihashi Y, Nakadaira Y, Kobayashi M, Tezuka M, Kosuge Y, Ishige K, Ito Y (2011) Deficient of a clock gene, brain and muscle Arnt-like protein-1 (BMAL1), induces dyslipidemia and ectopic fat formation. PLoS One 6(9): e25231
167. Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS (1997) Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J Clin Invest 99(5): 838
168. Shimomura I, Bashmakov Y, Ikemoto S, Horton JD, Brown MS, Goldstein JL (1999) Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 96(24): 13656-13661
169. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL (2000) Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6(1): 77-86
170. Smith S, Witkowski A, Joshi AK (2003) Structural and functional organization of the animal fatty acid synthase. Prog Lipid Res 42(4): 289-317
171. Sonksen P, Sonksen J (2000) Insulin: understanding its action in health and disease. Br J Anaesth 85(1): 69-79
172. Sookoian S, Gemma C, Gianotti TF, Burgueño A, Castaño G, Pirola CJ (2008) Genetic variants of Clock transcription factor are associated with individual susceptibility to obesity. Am J Clin Nutr 87(6): 1606-1615
173. Shi S-Q, Ansari TS, McGuinness OP, Wasserman DH, Johnson CH (2013) Circadian disruption leads to insulin resistance and obesity. Curr Biol 23(5): 372-381
174. Stoeckman AK, Ma L, Towle HC (2004) Mlx is the functional heteromeric partner of the carbohydrate response element-binding protein in glucose regulation of lipogenic enzyme genes. J Biol Chem 279(15): 15662-15669
175. Stoops JK, Arslanian MJ, Oh YH, Aune KC, Vanaman TC, Wakil SJ (1975) Presence of two polypeptide chains comprising fatty acid synthetase. Proc Natl Acad Sci U S A 72(5): 1940-1944
176. Strable MS, Ntambi JM (2010) Genetic control of de novo lipogenesis: role in diet-induced obesity. Crit Rev Biochem Mol Biol 45(3): 199-214
177. Sun Z, Lazar MA (2013) Dissociating fatty liver and diabetes. Trends Endocrinol Metab 24(1): 4-12
178. Sun L-P, Li L, Goldstein JL, Brown MS (2005) Insig required for sterol-mediated inhibition of Scap/SREBP binding to COPII proteins in vitro. J Biol Chem 280(28): 26483-26490
179. Sun L-P, Seemann J, Goldstein JL, Brown MS (2007) Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Insig renders sorting signal in Scap inaccessible to COPII proteins. Proc Natl Acad Sci U S A 104(16): 6519-6526
180. Sundqvist A, Bengoechea-Alonso MT, Ye X, Lukiyanchuk V, Jin J, Harper JW, Ericsson J (2005) Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF Fbw7. Cell Metab 1(6): 379-391
181. Swinnen JV, Brusselmans K, Verhoeven G (2006) Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 9(4): 358-365
182. Thompson KS, Towle H (1991) Localization of the carbohydrate response element of the rat L-type pyruvate kinase gene. J Biol Chem 266(14): 8679-8682
183. Tobin KAR, Ulven SM, Schuster GU, Steineger HH, Andresen SM, Gustafsson J-Å, Nebb HI (2002) Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis. J Biol Chem 277(12): 10691-10697
184. Tsatsos NG, Towle HC (2006) Glucose activation of ChREBP in hepatocytes occurs via a two-step mechanism. Biochem Biophys Res Commun 340(2): 449-456
185. Uchiyama A, Aoyama T, Kamijo K, Uchida Y, Kondo N, Orii T, Hashimoto T (1996) Molecular cloning of cDNA encoding rat very long-chain acyl-CoA synthetase. J Biol Chem 271(48): 30360-30365
186. Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J (2004) Absence of S6K1 protects against age-and diet-induced obesity while enhancing insulin sensitivity. Nature 431(7005): 200-205
187. Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, Hue L, Andreelli F (2006) Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. J Physiol 574(1): 41-53
188. Vluggens A, Reddy JK (2012) Nuclear receptors and transcription factors in the development of fatty liver disease. Curr Drug Metab 13(10): 1422-1435
189. Walker AK, Yang F, Jiang K, Ji J-Y, Watts JL, Purushotham A, Boss O, Hirsch ML, Ribich S, Smith JJ (2010) Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. Genes Dev 24(13): 1403-1417
190. Wang R-H, Kim H-S, Xiao C, Xu X, Gavrilova O, Deng C-X (2011) Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance. J Clin Invest 121(11): 4477
191. Welcker M, Clurman BE (2008) FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 8(2): 83-93
192. Wells L, Vosseller K, Hart G (2003) A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance. Cell Mol Life Sci 60(2): 222-228
193. Williams KJ, Argus JP, Zhu Y, Wilks MQ, Marbois BN, York AG, Kidani Y, Pourzia AL, Akhavan D, Lisiero DN (2013) An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity. Cancer Res 73(9): 2850-2862
194. Xu X, So J-S, Park J-G, Lee A-H (2013) Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP. Semin Liver Dis 33(4): 301-311 (NIH Public Access)
195. Yahagi N, Shimano H, Hasty AH, Matsuzaka T, Ide T, Yoshikawa T, Amemiya-Kudo M, Tomita S, Okazaki H, Tamura Y (2002) Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance inLep ob/Lep ob mice. J Biol Chem 277(22): 19353-19357
196. Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li YX, Diehl AM (2007) Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45(6): 1366-1374
197. Yamashita H, Takenoshita M, Sakurai M, Bruick RK, Henzel WJ, Shillinglaw W, Arnot D, Uyeda K (2001) A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci U S A 98(16): 9116-9121
198. Yamazaki Y, Usui I, Kanatani Y, Matsuya Y, Tsuneyama K, Fujisaka S, Bukhari A, Suzuki H, Senda S, Imanishi S (2009) Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice. Am J Physiol Endocrinol Metab 297(5): E1179-E1186
199. Yang J, Maika S, Craddock L, King JA, Liu Z-M (2008) Chronic activation of AMP-activated protein kinase-alpha1 in liver leads to decreased adiposity in mice. Biochem Biophys Res Commun 370(2): 248-253
200. Yang J, Craddock L, Hong S, Liu ZM (2009) AMP-activated protein kinase suppresses LXRdependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McARH7777 cells. J Cell Biochem 106(3): 414-426
201. Yap F, Craddock L, Yang J (2011) Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription. Int J Biol Sci 7(5): 645
202. Yecies J (2013) SREBP: a key effector of mTORC1 signaling in metabolism and cancer. Doctoral dissertation, Harvard University
203. Yecies JL, Zhang HH, Menon S, Liu S, Yecies D, Lipovsky AI, Gorgun C, Kwiatkowski DJ, Hotamisligil GS, Lee C-H (2011) Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab 14(1): 21-32
204. Yellaturu CR, Deng X, Cagen LM, Wilcox HG, Mansbach CM, Siddiqi SA, Park EA, Raghow R, Elam MB (2009) Insulin enhances post-translational processing of nascent SREBP-1c by promoting its phosphorylation and association with COPII vesicles. J Biol Chem 284(12): 7518-7532
205. Yki-Järvinen H (2005) Fat in the liver and insulin resistance. Ann Med 37(5): 347-356
206. Yu S, Rao S, Reddy JK (2003) Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis. Curr Mol Med 3(6): 561-572
207. Zeng L, Lu M, Mori K, Luo S, Lee AS, Zhu Y, Shyy JYJ (2004) ATF6 modulates SREBP2-mediated lipogenesis. EMBO J 23(4): 950-958
208. Zhang K, Wang S, Malhotra J, Hassler JR, Back SH, Wang G, Chang L, Xu W, Miao H, Leonardi R (2011) The unfolded protein response transducer IRE1α prevents ER stress-induced hepatic steatosis. EMBO J 30(7): 1357-1375
209. Zhang D, Tong X, Arthurs B, Guha A, Rui L, Kamath A, Inoki K, Yin L (2014) Liver clock protein BMAL1 promotes de novo lipogenesis through insulin-mTORC2-AKT signaling. J Biol Chem 289(37): 25925-25935
210. Zhao X, Feng D, Wang Q, Abdulla A, Xie X-J, Zhou J, Sun Y, Yang ES, Liu L-P, Vaitheesvaran B (2012) Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1. J Clin Invest 122(7): 2417
211. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108(8): 1167